DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen (PureTek Corporation)


Welcome to the PulseAid listing for the DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen drug offered from PureTek Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: PureTek Corporation
NON-PROPRIETARY NAME: avobenzone, octinoxate, octisalate, titanium dioxide
SUBSTANCE NAME: AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: LOTION
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2017-02-16
END MARKETING DATE: 0000-00-00


DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen HUMAN OTC DRUG Details:

Item DescriptionDermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen from PureTek Corporation
LABELER NAME: PureTek Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 25; 30; 30; 12.5(mg/mL; mg/mL; mg/mL; mg/mL)
START MARKETING DATE: 2017-02-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59088-568_758a637d-10f4-47db-87c2-705dbc593758
PRODUCT NDC: 59088-568
APPLICATION NUMBER: part352

Other AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
PureTek CorporationDermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen